This firm-fixed-price purchase order was awarded by the Bureau of Medicine and Surgery (a Defense agency) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $122,880.61 contract is for laboratory reagents and supplies, with a completion date of January 28, 2022. Life Technologies Corporation is a division of the parent company Thermo Electron Corporation, which has previously received various prime contracts and subcontracts with federal agencies like the National Cancer Institute, United States Geological Survey, and Bureau of Medicine and Surgery. This award did not utilize any set-aside designations. The original solicitation was a sole-source pre-solicitation notice, indicating Life Technologies Corporation was the only anticipated source due to its position as the manufacturer of the required proprietary reagents.